Literature DB >> 24370946

Utility of immunologic testing in suspected rheumatologic disease.

Monica Bhagat1, Shiv T Sehra, Anupama Shahane, Mildred Kwan.   

Abstract

The use of diagnostic testing in the clinical practice of medicine has been a shifting landscape from the time that the first blood test was utilized. This is no different in the field of immunology and in particular rheumatology. As the field of immunology is relatively young, the clinical tests are not well established and therefore guidelines for use are still under debate. In this review, we seek to look at some of the key autoantibodies, as well as other tests that are available to diagnose suspected rheumatologic disease, and examine how to best use these tests in the clinic. In particular, we will focus on the anti-nuclear antibodies, anti-neutrophil cytoplasmic antibodies, complement, cryoglobulins, rheumatoid factor, and anti-citrullinated protein antibodies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24370946     DOI: 10.1007/s11882-013-0405-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  76 in total

Review 1.  Rheumatoid factors: what do they tell us?

Authors:  Marianna M Newkirk
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

Review 2.  Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment.

Authors:  Oscar-Danilo Ortega-Hernandez; Yehuda Shoenfeld
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

3.  Outcome of positive antinuclear antibodies in individuals without connective tissue disease.

Authors:  Stephanie O Myckatyn; Anthony S Russell
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

4.  A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

Authors:  J A Savige; B Paspaliaris; R Silvestrini; D Davies; T Nikoloutsopoulos; A Sturgess; J Neil; W Pollock; K Dunster; M Hendle
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 5.  Rheumatoid factors: host resistance or autoimmunity?

Authors:  Marianna M Newkirk
Journal:  Clin Immunol       Date:  2002-07       Impact factor: 3.969

6.  The clinical utility of a positive antinuclear antibody test result.

Authors:  Aryeh M Abeles; Micha Abeles
Journal:  Am J Med       Date:  2013-02-08       Impact factor: 4.965

7.  Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection.

Authors:  Marie Matignon; Patrice Cacoub; Magali Colombat; David Saadoun; Isabelle Brocheriou; Béatrice Mougenot; Françoise Roudot-Thoraval; Philippe Vanhille; Olivier Moranne; Eric Hachulla; Pierre-Yves Hatron; Jean-Paul Fermand; Fadi Fakhouri; Pierre Ronco; Emmanuelle Plaisier; Philippe Grimbert
Journal:  Medicine (Baltimore)       Date:  2009-11       Impact factor: 1.889

Review 8.  Laboratory testing in pediatric rheumatology.

Authors:  Jay Mehta
Journal:  Pediatr Clin North Am       Date:  2012-04       Impact factor: 3.278

9.  Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titer.

Authors:  Peter N Malleson; Murray J Mackinnon; Michaela Sailer-Hoeck; Charles H Spencer
Journal:  Pediatr Rheumatol Online J       Date:  2010-10-20       Impact factor: 3.054

Review 10.  Rheumatoid factor, complement, and mixed cryoglobulinemia.

Authors:  Peter D Gorevic
Journal:  Clin Dev Immunol       Date:  2012-08-26
View more
  2 in total

1.  Diagnostic outcome and indications for testing in patients with positive ANCA at a Canadian tertiary care centre.

Authors:  Cyrus Chehroudi; Ronald A Booth; Nataliya Milman
Journal:  Rheumatol Int       Date:  2017-12-14       Impact factor: 2.631

2.  The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China.

Authors:  Jingjing Meng; Guoxiang Yang; Siting Li; Yueming Luo; Yina Bai; Chuiwen Deng; Ning Song; Mengtao Li; Xiaofeng Zeng; Chaojun Hu
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.